Tender detail

Open-house discount agreements for medicines containing depemokimab

Summary

The procurement concerns non-exclusive discount agreements for medicines containing the active ingredient depemokimab (ATC R03DX12). Agreements may be concluded at any time under the open-house model for the period from 1 January 2027 to 31 December 2028. Medicines included in the BfArM list of paediatric medicines under section 35(5a) of SGB V are excluded.

Reference number
40bc3fba-144e-4617-9d8c-a249ea1ab2fc
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-31
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.